Ionis Pharmaceuticals, Inc. Common Stock Share Price
NASDAQ: IONSHealthcare
Live Ionis Pharmaceuticals, Inc. Common Stock Share Price Chart
O H L
Ionis Pharmaceuticals, Inc. Common Stock Performance Overview
Days Range
▼
$45.81Low
$47.31High
Markets Today
| Previous Close | $44.84 |
|---|---|
| Open | $46.52 |
| Volume | 1,219,781 |
| Day's Range | $45.81 - $47.31 |
| 52W Range | $46.72 - $86.74 |
| Market Cap | $7.85 B |
Historical Performance
| 1M Returns | -23.52 |
|---|---|
| 3M Returns | -39.66 |
| 6M Returns | -38.01 |
| 1Y Returns | -26.70 |
| 5Y Returns | +20.51 |
| 10Y Returns | +41.72 |
Ionis Pharmaceuticals, Inc. Common Stock Fundamentals
| Market Cap | $7.85 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $943.71 M |
| ROE TTM | -0.71 |
| EPS TTM | $-3.47 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 17.80 |
| EBITDA | $-371.68 M |
| Profit Margin | -40.41 |
| Market Cap | $7.85 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $943.71 M |
| ROE TTM | -0.71 |
| EPS TTM | $-3.47 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 17.80 |
| EBITDA | $-371.68 M |
| Profit Margin | -40.41 |
Ionis Pharmaceuticals, Inc. Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $131.61 M | $452.05 M | $156.72 M | $203.33 M | $246.09 M | $267.95 M |
| Gross Profit + | $130.15 M | $447.90 M | $154.38 M | $195.37 M | $243.11 M | $265.21 M |
| Operating Income | -$146.86 M | $139.82 M | -$160.18 M | -$214.46 M | -$117.42 M | -$102.29 M |
| EBITDA | -$144.05 M | $142.68 M | -$157.31 M | -$213.00 M | -$113.46 M | -$98.16 M |
| Interest Expense | -$22.93 M | -$22.76 M | -$22.16 M | -$22.69 M | -$22.50 M | -$22.12 M |
| Depreciation | $2.81 M | $2.86 M | $2.88 M | $1.46 M | $3.96 M | $4.13 M |
| Income Before Tax | -$146.82 M | $123.53 M | -$128.39 M | -$227.92 M | -$92.31 M | -$113.38 M |
| Income Tax Expense | $116.00 K | -$20.00 K | $213.00 K | $1.48 M | $218.00 K | $1.26 M |
| Net Income + | -$146.94 M | $123.55 M | -$128.61 M | -$229.39 M | -$92.53 M | -$114.65 M |
| Net Profit Margin | -111.64% | 27.33% | -82.06% | -112.82% | -37.6% | -42.79% |
Ionis Pharmaceuticals, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $159.00 K | $159.00 K | $161.00 K | $163.00 K | $166.00 K | $166.00 K |
| Reserve & Surplus | -$2.43 B | -$2.30 B | -$2.43 B | -$2.66 B | -$2.75 B | -$2.87 B |
| Non-Current Liabilities | $2.09 B | $1.46 B | $1.51 B | $2.25 B | $2.24 B | $2.24 B |
| Current Liabilities | $250.29 M | $897.24 M | $903.46 M | $781.57 M | $716.59 M | $315.64 M |
| Total Liabilities | $2.34 B | $2.35 B | $2.42 B | $3.03 B | $2.96 B | $2.55 B |
| Fixed Assets | $102.92 M | $111.95 M | $106.12 M | $123.05 M | $142.40 M | $155.13 M |
| Current Assets | $2.42 B | $2.58 B | $2.52 B | $2.99 B | $2.94 B | $2.49 B |
| Total Assets | $2.81 B | $2.99 B | $3.03 B | $3.52 B | $3.45 B | $2.99 B |
Ionis Pharmaceuticals, Inc. Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$146.94 M | $123.55 M | -$128.61 M | -$229.39 M | -$92.53 M | -$114.65 M |
| Operating Cash Flow | -$150.78 M | $151.34 M | -$131.44 M | -$137.71 M | -$792.82 M | $565.53 M |
| Investing Cash Flow | $170.46 M | -$120.07 M | $91.34 M | -$419.50 M | $536.82 M | $23.50 M |
| Financing Cash Flow | $2.20 M | $1.25 M | $81.22 M | $591.18 M | $57.26 M | -$412.29 M |
| Change in Cash | $22.11 M | $33.11 M | $41.04 M | $33.92 M | -$198.88 M | $176.68 M |
Ionis Pharmaceuticals, Inc. Common Stock Return Calculator
The Ionis Pharmaceuticals, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$12,596
Invested Amount$10,000
Est. Returns$2,596
About Ionis Pharmaceuticals, Inc. Common Stock
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and Biogen brought Spinraza to market in 2016 as a treatment for spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024. Ionis marked its first two independent launches in 2025 for Tryngolza (for FCS) and Dawnzera (for HAE).
Popular Stocks
FAQs
What is the share price of Ionis Pharmaceuticals, Inc. Common Stock today?
Ionis Pharmaceuticals, Inc. Common Stock (IONS) share price as of September 17, 2026 is $46.87. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Ionis Pharmaceuticals, Inc. Common Stock?
Yes, Indian Investors can invest in the Ionis Pharmaceuticals, Inc. Common Stock (IONS) Share by opening an international trading account with Angel One.
How can I purchase Ionis Pharmaceuticals, Inc. Common Stock shares in India?
Purchasing Ionis Pharmaceuticals, Inc. Common Stock (IONS) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Ionis Pharmaceuticals, Inc. Common Stock (IONS) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Ionis Pharmaceuticals, Inc. Common Stock?
Yes, you can purchase fractional shares of Ionis Pharmaceuticals, Inc. Common Stock (IONS) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Ionis Pharmaceuticals, Inc. Common Stock?
The market capitalization of Ionis Pharmaceuticals, Inc. Common Stock on September 17, 2026, is $7.85 B.
In which sector Ionis Pharmaceuticals, Inc. Common Stock belongs?
Ionis Pharmaceuticals, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Ionis Pharmaceuticals, Inc. Common Stock stocks?
In order to invest in Ionis Pharmaceuticals, Inc. Common Stock (IONS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
